Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
2.750
+0.020 (0.73%)
At close: Jul 23, 2025, 4:00 PM
2.810
+0.060 (2.18%)
After-hours: Jul 23, 2025, 7:06 PM EDT

Purple Biotech Statistics

Total Valuation

Purple Biotech has a market cap or net worth of $8.01 million. The enterprise value is $296,119.

Market Cap8.01M
Enterprise Value 296,119

Important Dates

The next estimated earnings date is Friday, August 15, 2025, before market open.

Earnings Date Aug 15, 2025
Ex-Dividend Date n/a

Share Statistics

Purple Biotech has 526.45 million shares outstanding. The number of shares has increased by 63.55% in one year.

Current Share Class n/a
Shares Outstanding 526.45M
Shares Change (YoY) +63.55%
Shares Change (QoQ) +28.32%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 561.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.25
P/TBV Ratio 1.67
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.00.

Current Ratio 2.72
Quick Ratio 2.57
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -430.17

Financial Efficiency

Return on equity (ROE) is -12.40% and return on invested capital (ROIC) is -15.07%.

Return on Equity (ROE) -12.40%
Return on Assets (ROA) -12.83%
Return on Invested Capital (ROIC) -15.07%
Return on Capital Employed (ROCE) -23.58%
Revenue Per Employee n/a
Profits Per Employee -$436,778
Employee Count9
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -60.83% in the last 52 weeks. The beta is -0.74, so Purple Biotech's price volatility has been lower than the market average.

Beta (5Y) -0.74
52-Week Price Change -60.83%
50-Day Moving Average 2.46
200-Day Moving Average 3.10
Relative Strength Index (RSI) 65.26
Average Volume (20 Days) 19,996

Short Selling Information

Short Interest 144,549
Short Previous Month 147,340
Short % of Shares Out 5.61%
Short % of Float n/a
Short Ratio (days to cover) 5.13

Income Statement

Revenue n/a
Gross Profit -62,000
Operating Income -7.74M
Pretax Income 18.76M
Net Income -3.93M
EBITDA -7.71M
EBIT -7.74M
Earnings Per Share (EPS) -$0.01
Full Income Statement

Balance Sheet

The company has $7.09 million in cash and $137,000 in debt, giving a net cash position of $6.95 million or $0.01 per share.

Cash & Cash Equivalents 7.09M
Total Debt 137,000
Net Cash 6.95M
Net Cash Per Share $0.01
Equity (Book Value) 32.70M
Book Value Per Share 0.06
Working Capital 4.76M
Full Balance Sheet

Cash Flow

Operating Cash Flow -11.26M
Capital Expenditures n/a
Free Cash Flow -11.26M
FCF Per Share -$0.02
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Purple Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -63.55%
Shareholder Yield -63.55%
Earnings Yield -49.05%
FCF Yield -140.55%

Analyst Forecast

The average price target for Purple Biotech is $33.00, which is 1,100.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $33.00
Price Target Difference 1,100.00%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 17, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date Sep 17, 2024
Split Type Reverse
Split Ratio 0.05:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1